A phase II double blind, placebo controlled, randomized trial to determine the efficacy and safety of Gemcabene in patients with osteoarthritis of the knee.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Gemcabene (Primary) ; Rofecoxib
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- 19 Apr 2017 New trial record